Preliminary Outcome and Quality of Life among Geriatric Head and Neck Cancer (GHNC) Patients Treated with Institutional Nimorad (Nimotuzumab-Modulated Radiotherapy) Protocol.

Saved in:
Bibliographic Details
Title: Preliminary Outcome and Quality of Life among Geriatric Head and Neck Cancer (GHNC) Patients Treated with Institutional Nimorad (Nimotuzumab-Modulated Radiotherapy) Protocol.
Authors: Basu, T.1 (AUTHOR), Senapati, M.R.1 (AUTHOR), Karpe, A.2 (AUTHOR), Mahuvakar, A.3 (AUTHOR), Mathur, Y.3 (AUTHOR), Ambulkar, I.4 (AUTHOR), Dsouza, H.2 (AUTHOR), Saxena, U.1 (AUTHOR), E, R.K.5 (AUTHOR), Rajurkar, S.5 (AUTHOR)
Source: International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pe450-e450. 1p.
Database: Academic Search Ultimate
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2022.07.1679